Healing response to the Clamshell device for closure of intracardiac defects in humans

被引:34
作者
Kreutzer, J
Ryan, CA
Gauvreau, K
Van Praagh, R
Anderson, JM
Jenkins, KJ
机构
[1] Univ Penn, Div Cardiol, Dept Pediat, Philadelphia, PA 19104 USA
[2] NMT Med Inc, Boston, MA USA
[3] Harvard Univ, Sch Med, Dept Pediat, Childrens Hosp,Dept Cardiol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dept Pathol, Childrens Hosp, Boston, MA 02115 USA
[5] Case Western Reserve Univ, Univ Hosp, Dept Pathol, Cleveland, OH 44106 USA
关键词
cardiac catheterization; atrial septal defect; histopathology;
D O I
10.1002/ccd.1248
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The healing response to intracardiac devices in humans is largely unknown. During regulatory trials using the Clamshell device in over 800 patients, attempts were made to perform histopathological evaluation of all explanted devices. We reviewed all those with complete histopathological examination (n = 12) from Fontan baffles (n = 4), ventricular septal defects (n = 2), and atrial septal defects (ASD; n = 6), explanted at 2.7 months to 3.6 years (median, 1.6 years), at autopsy (n = 1) or surgery (n = 11), performed for residual defects (n = 5), atrial masses (n = 3), or Fontan revision (n = 3). All but one were nearly (n = 3) or completely (n = 8) covered by pseudointima, composed of fibroelastic tissue, predominantly collagen, with focal foreign body reaction in contact with fabric, without acute inflammation or infection. Atrial masses of granulation tissue were present in three cases (ASD), opposite to protruding fractured arms. No associations were identified between coverage and closure status, position, arm fractures, or implant period. In conclusion, the healing response to transcatheter Clamshell implantation in humans is characterized by a relatively rapid development of a nonthrombotic pseudointima composed of fibroelastic tissue with minimal foreign body reaction. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:101 / 111
页数:11
相关论文
共 21 条
[1]  
ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS199
[2]  
Beekman RH, 1989, J INTERV CARDIOL, V2, P35
[3]   TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE AFTER PRESUMED PARADOXICAL EMBOLISM [J].
BRIDGES, ND ;
HELLENBRAND, W ;
LATSON, L ;
FILIANO, J ;
NEWBURGER, JW ;
LOCK, JE .
CIRCULATION, 1992, 86 (06) :1902-1908
[4]   EXPERIMENTAL ATRIAL SEPTAL-DEFECT CLOSURE WITH A NEW, TRANSCATHETER, SELF-CENTERING DEVICE [J].
DAS, GS ;
VOSS, G ;
JARVIS, G ;
WYCHE, K ;
GUNTHER, R ;
WILSON, RF .
CIRCULATION, 1993, 88 (04) :1754-1764
[5]  
Han YM, 1999, CATHETER CARDIO INTE, V47, P370, DOI 10.1002/(SICI)1522-726X(199907)47:3<370::AID-CCD27>3.0.CO
[6]  
2-9
[7]  
JENKINS KJ, 1995, CIRCULATION, V92, P308
[8]  
Kreutzer J, 2000, CATHETER CARDIO INTE, V49, P225, DOI 10.1002/(SICI)1522-726X(200002)49:2<225::AID-CCD25>3.0.CO
[9]  
2-S
[10]   Biological response to bard Clamshell Septal Occluders in the canine heart [J].
Kuhn, MA ;
Latson, LA ;
Cheatham, JP ;
McManus, B ;
Anderson, JM ;
Kilzer, KL ;
Furst, J .
CIRCULATION, 1996, 93 (07) :1459-1463